This document is an FCC Authorization letter from AKUVOX (XIAMEN) NETWORKS CO., LTD., dated September 25, 2024. It authorizes Bay Area Compliance Laboratories Corp.(Xiamen) to act on AKUVOX's behalf in all matters relating to application for Equipment authorization, including the signing of all documents relating to these matters. The letter confirms that all acts carried out by Bay Area Compliance Laboratories Corp.(Xiamen) on AKUVOX's behalf shall have the same effect as AKUVOX's own action.
The letter also includes a statement certifying that AKUVOX is not subject to a denial of federal benefits, including FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. The authorization is valid until further written notice from the applicant. The document is signed by Bo Yang, Manager, and includes the QA-FR-170-B identifier.
Array
(
[0] => Array
(
[url_sha] => 0e8c94da9a54bee26b553994edb8cff9eb679e2bbab29dfa69e5533414196985
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8075835
[href_text] => FCC Agent Authorization Letter
[href_description] => AKUVOX (XIAMEN) NETWORKS CO., LTD. PG71 2AHCR-PG71 2AHCRPG71 pg71
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] => application/pdf
[http_filename] => GetApplicationAttachment.html?id=8075835
[http_size] => 75060
[file_sha256] => 3ac6dc657b8de0dfeaeb94853d747feb2018937a6fcf2495d88b16cb36f0f51a
[domain] => document.fccid
)
[1] => Array
(
[url_sha] => b557959bf2c5e49cc1b43ba39fd1b632587661b3f79424c46a83740629e31ed9
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8075907
[href_text] => FCC Agent Authorization Letter
[href_description] => AKUVOX (XIAMEN) NETWORKS CO., LTD. PG71 HyPanel Pro 2AHCR-PG71 2AHCRPG71 pg71
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] => application/pdf
[http_filename] => GetApplicationAttachment.html?id=8075907
[http_size] => 75060
[file_sha256] => 3ac6dc657b8de0dfeaeb94853d747feb2018937a6fcf2495d88b16cb36f0f51a
[domain] => document.fccid
)
[2] => Array
(
[url_sha] => 2f61f66e8636cae058d1adffb8359ee2aacd93caf68d298706b65a19ee95605d
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8075873
[href_text] => FCC Agent Authorization Letter
[href_description] => AKUVOX (XIAMEN) NETWORKS CO., LTD. PG71 HyPanel Pro 2AHCR-PG71 2AHCRPG71 pg71
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] => application/pdf
[http_filename] => GetApplicationAttachment.html?id=8075873
[http_size] => 75060
[file_sha256] => 3ac6dc657b8de0dfeaeb94853d747feb2018937a6fcf2495d88b16cb36f0f51a
[domain] => document.fccid
)
)
Array
(
[file_sha256] => 3ac6dc657b8de0dfeaeb94853d747feb2018937a6fcf2495d88b16cb36f0f51a
[cleanFccId] => 2AHCRPG71
[title] => FCC Authorization Letter for AKUVOX (XIAMEN) NETWORKS CO., LTD.
[description] => Agent authorization letter from AKUVOX (XIAMEN) NETWORKS CO., LTD. authorizing Bay Area Compliance Laboratories Corp.(Xiamen).
[brand_name] => AKUVOX
[keywords] => []
[intro] =>
This document is an FCC Authorization letter from AKUVOX (XIAMEN) NETWORKS CO., LTD., dated September 25, 2024. It authorizes Bay Area Compliance Laboratories Corp.(Xiamen) to act on AKUVOX's behalf in all matters relating to application for Equipment authorization, including the signing of all documents relating to these matters. The letter confirms that all acts carried out by Bay Area Compliance Laboratories Corp.(Xiamen) on AKUVOX's behalf shall have the same effect as AKUVOX's own action.
The letter also includes a statement certifying that AKUVOX is not subject to a denial of federal benefits, including FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. The authorization is valid until further written notice from the applicant. The document is signed by Bo Yang, Manager, and includes the QA-FR-170-B identifier.
)
Array
(
[0] => Array
(
[id] => 8075835
[file_sha256] =>
[applicationId] => sfN9gQ+aNTelH5DQXaQLCg==
[description] => FCC Agent Authorization Letter
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => Cover Letter(s)
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 75062
[submissionDate] => 2025-02-26 00:00:00
[dateAvailable] => 2025-02-26 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2AHCR-PG71
[cleanFccId] => 2AHCRPG71
[exif] => 0
)
)